Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25829813 | 0.84 | PLA2G4A (0.36) | — | |
| SCHEMBL24140371 | 0.84 | PLA2G4A (0.38) | ABCB1 | |
| SCHEMBL17728724 | 0.81 | — | — | |
| SCHEMBL17739852 | 0.81 | CTSK (0.34) | ABCB1 | |
| SCHEMBL15033314 | 0.79 | PLA2G4A (0.31) | ABCB1 | |
| SCHEMBL23551975 | 0.79 | PLA2G4A (0.31) | ABCB1 | |
| SCHEMBL24872391 | 0.79 | PLA2G4A (0.31) | ABCB1 | |
| SCHEMBL25825751 | 0.78 | ABCB1 (0.32) | ABCB1 | |
| SCHEMBL18542105 | 0.77 | PLA2G4A (0.33) | — | |
| SCHEMBL19293115 | 0.76 | PLA2G4A (0.32) | ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160130299-A1 | TUBULYSIN ANALOGS AND METHODS OF MAKING AND USE | BRISTOL-MYERS SQUIBB COMPANY | 2016-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160130299-A1 | TUBULYSIN ANALOGS AND METHODS OF MAKING AND USE | CCNY, CDC45, TPX2 | ABCB1 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.